The Identification of Escherichia coli Virulence Gene from Diabetic Foot Ulcer (DFU) at the Diabetes Care Home, Bekasi, West Java, Indonesia
DOI:
https://doi.org/10.24233/biov.11.1.2025.448Keywords:
diabetic; E.coli; Whole Genome Sequence; virulensi; geneAbstract
One of the complications of diabetes is diabetic foot ulcer (DFU). One of the bacteria that shows a high prevalence in DFU patients is Escherichia coli. The purpose of this study to determine the virulence gene in E.coli isolated from DFU patients at the Bekasi Diabetes Care Home, West Java, Indonesia. Detection of E.coli virulence genes was carried out using the Whole Genome Sequence (WGS) method. Data analysis was carried out descriptively. This study showed the presence of fdeC, fimH, astA, hlyE, hlyF, csgA, and cvaC genes. This study concluded that the fdeC and fimH genes encode protein expression for the formation of colonisation or biofilm, astA, hlyE, and hlyF genes encode the expression of enterotoxin and hemolysin, csgA genes, and cvaC encode the expression of colicin, Curlin, and microcin C bacteriocin.
Last Year PDF Downloads
References
S. K. Das et al., “Diabetic Foot Ulcer Identification: A Review,” Jun. 01, 2023, Multidisciplinary Digital Publishing Institute (MDPI). doi: 10.3390/diagnostics13121998.
M. S. Baig et al., “An Overview of Diabetic Foot Ulcers and Associated Problems with Special Emphasis on Treatments with Antimicrobials,” Jul. 01, 2022, MDPI. Doi: 10.3390/life12071054.
“2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022,” Diabetes Care, vol. 45, pp. S17–S38, Jan. 2022, doi: 10.2337/dc22-S002.
S. H. Lee, S. H. Kim, K. B. Kim, H. S. Kim, and Y. K. Lee, “Factors Influencing Wound Healing in Diabetic Foot Patients,” Medicina (Lithuania), vol. 60, no. 5, May 2024, doi: 10.3390/medicina60050723.
Z. Salsabila and A. C. Sjaaf, “The Analysis Of Diabetes Self-Management Implementation On Type 2 Diabetes Mellitus Patients: A Protocol For Systematic Review And Meta-Analysis,” Jurnal Ekonomi Kesehatan Indonesia, vol. 7, no. 2, p. 133, Dec. 2022, doi: 10.7454/eki.v7i2.6100.
A. Z. Safitri, R. N. Fajariyah, and E. Astutik, “Risk Factors of Diabetes Mellitus in Urban Communities in Indonesia (IFLS 5),” Jurnal Berkala Epidemiologi, vol. 9, no. 2, p. 184, May 2021, doi: 10.20473/jbe.v9i22021.184-191.
J. A. Rubio, S. Jiménez, and J. L. Lázaro-Martínez, “Mortality in patients with diabetic foot ulcers: Causes, risk factors, and their association with evolution and severity of ulcer,” J Clin Med, vol. 9, no. 9, pp. 1–14, Sep. 2020, doi: 10.3390/jcm9093009.
R. Da Ros et al., “Burden of Infected Diabetic Foot Ulcers on Hospital Admissions and Costs in a Third-Level Center,” Diabetology, vol. 5, no. 2, pp. 141–150, Jun. 2024, doi: 10.3390/diabetology5020011.
“Antibiotics Susceptibility Pattern in Diabetic Ulcer Patients.” [Online]. Available: www.indonesianjournalofclinicalpathology.org
M. Idrees et al., “Bacterial spectrum from diabetic foot Ulcers: A study of antibiotic resistance patterns and phylogenetic diversity,” J King Saud Univ Sci, vol. 36, no. 8, Sep. 2024, doi: 10.1016/j.jksus.2024.103320.
S. Jain and R. Barman, “Bacteriological profile of diabetic foot ulcer with special reference to drug-resistant strains in a tertiary care center in North-East India,” Indian J Endocrinol Metab, vol. 21, no. 5, pp. 688–694, Sep. 2017, doi: 10.4103/ijem.IJEM_546_16.
H. Anita et al., “Bacterial etiology, antibiotic resistance profile and foot ulcer associated amputations in individuals with Type II diabetes mellitus,” J King Saud Univ Sci, vol. 35, no. 8, Nov. 2023, doi: 10.1016/j.jksus.2023.102891.
F. J. Álvaro-Afonso, Y. García-Álvarez, A. Tardáguila-García, M. García-Madrid, M. López-Moral, and J. L. Lázaro-Martínez, “Bacterial Diversity and Antibiotic Resistance in Patients with Diabetic Foot Osteomyelitis,” Antibiotics, vol. 12, no. 2, Feb. 2023, doi 10.3390/antibiotics12020212.
P. Baral et al., “Bacteriological analysis and antibiotic resistance in patients with diabetic foot ulcers in Dhaka,” PLoS One, vol. 19, no. 5 May, May 2024, doi: 10.1371/journal.pone.0301767.
M.-L. Shi, X.-R. Quan, L.-M. Tan, H.-L. Zhang, and A.-Q. Yang, “Identification and antibiotic susceptibility of microorganisms isolated from diabetic foot ulcers: A pathological aspect,” Exp Ther Med, vol. 25, no. 1, Dec. 2022, doi: 10.3892/etm.2022.11752.
P. A. Surendra and H. Novida, “702 Medico-legal Update.”
R. Sari, P. Apridamayanti, and I. Diah Puspita, “Sensitivity of Escherichia coli Bacteria Towards Antibiotics in Patient with Diabetic Foot Ulcer ARTICLE HISTORY,” Pharmaceutical Sciences and Research, vol. 5, no. 1, pp. 19–24, 2018.
T. Konno, J. Yatsuyanagi, and S. Saito, “Virulence gene profiling of enteroaggregative Escherichia coli heat-stable enterotoxin 1-harbouring E. coli (EAST1EC) derived from sporadic diarrheal patients,” FEMS Immunol Med Microbiol, vol. 64, no. 3, pp. 314–320, Apr. 2012, doi: 10.1111/j.1574-695X.2011.00913.x.
L. E. P. Silva, T. B. Souza, N. P. Silva, and I. C. A. Scaletsky, “Detection and genetic analysis of the enteroaggregative Escherichia coli heat-stable enterotoxin (EAST1) gene in clinical isolates of enteropathogenic Escherichia coli (EPEC) strains,” BMC Microbiol, vol. 14, no. 1, May 2014, doi: 10.1186/1471-2180-14-135.
L. C. Spano, K. F. da Cunha, M. V. Monfardini, R. de Cássia Bergamaschi Fonseca, and I. C. A. Scaletsky, “High prevalence of diarrheagenic Escherichia coli carrying toxin-encoding genes isolated from children and adults in southeastern Brazil,” BMC Infect Dis, vol. 17, no. 1, Dec. 2017, doi: 10.1186/s12879-017-2872-0.
F. Gigliucci et al., “Genomic characterization of hlyf-positive shiga toxin–producing escherichia coli, Italy and the Netherlands, 2000–2019,” Mar. 01, 2021, Centers for Disease Control and Prevention (CDC). doi: 10.3201/eid2703.203110.
L. C. Ristow and R. A. Welch, “Hemolysin of uropathogenic Escherichia coli: A cloak or a dagger?,” Mar. 01, 2016, Elsevier B.V. doi: 10.1016/j.bbamem.2015.08.015.
R. A. Welch, “ The Escherichia coli Hemolysin ,” EcoSal Plus, vol. 1, no. 2, Jan. 2005, doi: 10.1128/ecosalplus.8.7.2.
H. Barreteau, D. Patin, A. Bouhss, D. Blanot, D. Mengin-Lecreulx, and T. Touzé, “CbrA Mediates Colicin M Resistance in Escherichia coli through Modification of Undecaprenyl-Phosphate-Linked Peptidoglycan Precursors,” 2020. [Online]. Available: https://doi.org/10
N. Shcherbak, H. Prochaska, K. Lystvan, Y. Prokhorova, A. Giritch, and M. Kuchuk, “Accumulation of colicin M protein and its biological activity in transgenic lettuce and mizuna plants,” Front Plant Sci, vol. 14, 2023, doi: 10.3389/fpls.2023.1271757.
V. D’Onofrio, R. Cartuyvels, P. E. A. Messiaen, I. Barišić, and I. C. Gyssens, “Virulence Factor Genes in Invasive Escherichia coli Are Associated with Clinical Outcomes and Disease Severity in Patients with Sepsis: A Prospective Observational Cohort Study,” Microorganisms, vol. 11, no. 7, Jul. 2023, doi: 10.3390/microorganisms11071827.
J. K. Parker and B. W. Davies, “Microcins reveal natural mechanisms of bacterial manipulation to inform therapeutic development,” 2022, Microbiology Society. doi: 10.1099/mic.0.001175.
F. Baquero, V. F. Lanza, M. R. Baquero, R. del Campo, and D. A. Bravo-Vázquez, “Microcins in Enterobacteriaceae: Peptide Antimicrobials in the Eco-Active Intestinal Chemosphere,” Oct. 09, 2019, Frontiers Media S.A. doi: 10.3389/fmicb.2019.02261.
X. Wang, Y. Zhou, J. J. Ren, N. D. Hammer, and M. R. Chapman, “Gatekeeper residues in the major curlin subunit modulate bacterial amyloid fibre biogenesis,” Proc Natl Acad Sci U S A, vol. 107, no. 1, pp. 163–168, 2010, doi: 10.1073/pnas.0908714107.
F. Bu, D. R. Dee, and B. Liu, “Structural insight into Escherichia coli CsgA amyloid fibril assembly,” mBio, vol. 15, no. 4, Apr. 2024, doi: 10.1128/mbio.00419-24.
PDF Downloads: 16
Published
How to Cite
Write scientific names with Italic fonts:
Issue
Section
Copyright (c) 2025 Maulin Inggraini, Reza Anindita, Noor Andryan Ilsan, Siti Nurfajriah
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
d. Authors hold the copyright and retain publishing right of articles without restrictions.
.gif)
